[Effects of SERMs on bone health. Combination therapy with raloxifene]
- PMID: 20190371
[Effects of SERMs on bone health. Combination therapy with raloxifene]
Abstract
It is generally considered that drugs with different pharmacological actions are prescribed when combination therapy is undertaken. Vitamin D insufficiency or deficiency is prevalent in osteopenic and osteoporotic postmenopausal women. Combination therapy of raloxifene with other agents including vitamin D has been reported and its effect on fracture prevention remains to be elucidated.
Similar articles
-
[Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].Clin Calcium. 2010 Mar;20(3):396-407. Clin Calcium. 2010. PMID: 20190370 Review. Japanese.
-
[Long term effects of raloxifen on the bones].Ugeskr Laeger. 2008 Jan 21;170(4):224-6. Ugeskr Laeger. 2008. PMID: 18282451 Danish.
-
[Current osteoporosis treatment: reasons for adding vitamin D to alendronate].Reumatizam. 2006;53(2):63-5. Reumatizam. 2006. PMID: 17580557 Review. Croatian.
-
The effect of raloxifene in association with vitamin D on vaginal maturation index and urogenital symptoms in postmenopausal osteoporotic women.Fertil Steril. 2007 Aug;88(2):530-2. doi: 10.1016/j.fertnstert.2006.11.112. Epub 2007 Mar 6. Fertil Steril. 2007. PMID: 17336964 Clinical Trial.
-
[Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].Clin Calcium. 2008 Oct;18(10):1442-50. Clin Calcium. 2008. PMID: 18830041 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical